LifeStance Health Group Inc
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
LFST$14.56-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
(In thousands, except for Net Loss per Share)
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| TOTAL REVENUE | $1,055,665 | $859,542 | $667,511 |
| OPERATING EXPENSES | |||
| Center costs, excluding depreciation and amortization shown separately below | 753,569 | 622,525 | 466,003 |
| General and administrative expenses | 410,793 | 377,993 | 433,725 |
| Depreciation and amortization | 80,437 | 69,198 | 54,136 |
| Total operating expenses | $1,244,799 | $1,069,716 | $953,864 |
| LOSS FROM OPERATIONS | $(189,134) | $(210,174) | $(286,353) |
| OTHER EXPENSE | |||
| Gain (loss) on remeasurement of contingent consideration | 3,972 | (1,688) | (2,610) |
| Transaction costs | (89) | (722) | (3,762) |
| Interest expense, net | (21,220) | (19,928) | (38,911) |
| Other expense | (112) | (218) | (1,469) |
| Total other expense | $(17,449) | $(22,556) | $(46,752) |
| LOSS BEFORE INCOME TAXES | (206,583) | (232,730) | (333,105) |
| INCOME TAX BENEFIT | 20,321 | 17,166 | 25,908 |
| NET LOSS | $(186,262) | $(215,564) | $(307,197) |
| Accretion of Redeemable Class A units | — | — | (36,750) |
| NET LOSS AVAILABLE TO COMMON STOCKHOLDERS/MEMBERS | $(186,262) | $(215,564) | $(343,947) |
| NET LOSS PER SHARE, BASIC AND DILUTED | (0.51) | (0.61) | (1.05) |
| Weighted-average shares used to compute basic and diluted net loss per share | 367,457 | 355,278 | 327,523 |
| NET LOSS | $(186,262) | $(215,564) | $(307,197) |
| OTHER COMPREHENSIVE (LOSS) INCOME | |||
| Unrealized (losses) gains on cash flow hedge, net of tax | (971) | 3,274 | — |
| COMPREHENSIVE LOSS | $(187,233) | $(212,290) | $(307,197) |
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
| Common Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders' | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Income | Deficit | Equity | |
| Balances at December 31, 2022 | 375,964 | $3,761 | $2,084,324 | $3,274 | $(572,636) | $1,518,723 |
| Net loss | — | — | — | — | (186,262) | (186,262) |
| Adoption of ASU 2016-13 | — | — | — | — | (1,948) | (1,948) |
| Issuance of common stock upon vesting of restricted stock units | 4,831 | 48 | (48) | — | — | — |
| Forfeitures | (2,070) | (20) | (3,379) | — | — | (3,399) |
| Other comprehensive loss | — | — | — | (971) | — | (971) |
| Stock-based compensation expense | — | — | 102,787 | — | — | 102,787 |
| Balances at December 31, 2023 | 378,725 | $3,789 | $2,183,684 | $2,303 | $(760,846) | $1,428,930 |
| Common Stock · AdditionalPaid-in · Accumulated Other Comprehensive · Accumulated · Total Stockholders' | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Capital | Income | Deficit | Equity | |
| Balances at December 31, 2021 | 374,255 | $3,743 | $1,898,357 | $— | $(357,072) | $1,545,028 |
| Net loss | — | — | — | — | (215,564) | (215,564) |
| Issuance of common stock upon vesting of restricted stock units | 2,204 | 22 | (485) | — | — | (463) |
| Forfeitures | (363) | (3) | (1,357) | — | — | (1,360) |
| Surrender of common stock | (132) | (1) | (981) | — | — | (982) |
| Other comprehensive income | — | — | — | 3,274 | — | 3,274 |
| Stock-based compensation expense | — | — | 188,790 | — | — | 188,790 |
| Balances at December 31, 2022 | 375,964 | $3,761 | $2,084,324 | $3,274 | $(572,636) | $1,518,723 |
CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE UNITS AND STOCKHOLDERS'/MEMBERS’ EQUITY
| Class A Redeemable Units · Class A-1 Common Units · Class A-2 Common Units · Class B Common Units · Common Stock · AdditionalPaid-in · Accumulated · Total Stockholders'/Members' | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Units | Amount | Units | Amount | Units | Amount | Units | Amount | Shares | Amount | Capital | Deficit | Equity | |
| Balances at December 31, 2020 | 35,000 | $35,000 | 959,563 | $959,563 | 49,946 | $49,946 | — | $— | — | $— | $1,452 | $(13,125) | $997,836 |
| Net loss | — | — | — | — | — | — | — | — | — | — | — | (307,197) | (307,197) |
| Issuance of common units | — | — | — | — | 962 | 1,000 | — | — | — | — | — | — | 1,000 |
| Accretion of Redeemable Class A Units | — | 36,750 | — | — | — | — | — | — | — | — | — | (36,750) | (36,750) |
| Issuance of common units for acquisitions of businesses | — | — | — | — | 725 | 1,486 | — | — | — | — | — | — | 1,486 |
| Vesting of Class B Profits Interests | — | — | — | — | — | — | 17,920 | — | — | — | — | — | — |
| Conversion of Redeemable Class A Units into common stock upon closing of initial public offering | (35,000) | (71,750) | — | — | — | — | — | — | 10,234 | 102 | 71,648 | — | 71,750 |
| Conversion of common units into common stock upon closing of initial public offering | — | — | (959,563) | (959,563) | (51,633) | (52,432) | — | — | 295,663 | 2,957 | 1,009,038 | — | — |
| Conversion of vested Class B Profits Interests to common stock upon closing of initial public offering | — | — | — | — | — | — | (17,920) | — | 4,186 | 42 | (42) | — | — |
| Conversion of unvested Class B Profits Interests to restricted stock upon closing of initial public offering | — | — | — | — | — | — | — | — | 30,766 | 308 | (308) | — | — |
| Issuance of common stock upon closing of initial public offering, net | — | — | — | — | — | — | — | — | 32,800 | 328 | 548,577 | — | 548,905 |
| Endowment of shares to the LifeStance Health Foundation | — | — | — | — | — | — | — | — | 500 | 5 | 8,995 | — | 9,000 |
| Issuance of common stock upon vesting of restricted stock units | — | — | — | — | — | — | — | — | 106 | 1 | (442) | — | (441) |
| Stock and unit-based compensation expense | — | — | — | — | — | — | — | — | — | — | 259,439 | — | 259,439 |
| Balances at December 31, 2021 | — | $— | — | $— | — | $— | — | $— | 374,255 | $3,743 | $1,898,357 | $(357,072) | $1,545,028 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.